Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05639751
Title	PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Prelude Therapeutics
Indications	Advanced Solid Tumor
Therapies	Docetaxel + PRT3789 PRT3789
Age Groups:	adult \| senior
Covered Countries	USA \| NLD \| FRA \| ESP